1. HOME>
  2. About DAILAB



DBT-AIST International Laboratory for Advanced Biomedicine DAILAB


Under the Joint Statement towards Japan-India Strategic and Global Partnership of December 2006, signed by the prime ministers of India and Japan, the National Institute of Advanced Industrial Science & Technology (AIST), Japan concluded a comprehensive Memorandum of Understanding (MoU) with the Department of Biotechnology (DBT) of the Ministry of Science and Technology, India on February 12, 2007.

img01 After the successful completion of the first term of MoU the two institutes entered the second term 2012-2018. The MoU involved bilateral collaboration on three themes - Bioinformatics, Biomedicine and Glycosciences. Under this agreement, AIST and DBT scientists have been collaborating on selected projects at both ends. Four workshops, two at each side, were held for exchange of ideas, information and research results, besides exchange of personnel, and to develop closer cooperation and collaboration between the two institutions.

In order to promote close and effective collaboration, DBT and AIST have set up a joint laboratory, DAILAB (DBT-AIST International Laboratory for Advanced Biomedicine) at the Biomedical Research Institute (BMRI), AIST, Japan. DAILAB is conducting multiplatform basic to applied research on drug discovery and assets innovation for increasing the quality of life (with focus on old age). In addition, training, networking of young researchers is done by a variety of ongoing programs including inviting students and young PIs to BMRI for short and long term. This is the first time that the AIST and DBT are hosting an International laboratory in Life Sciences & Biotechnology.



Sunil Kaul
DAILAB, Biomedical Research Institute, AIST
1-1-1 Higashi, Tsukuba-shi, Ibaraki 305-8562, Japan
E-mail: s-kaul@aist.go.jp